FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S. 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge 
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue 
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power 
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit 
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling 
OLATHE, Kan., March 01, 2016 -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the NTrainer System® demonstrated improved transition to independent oral feeding. The improvements led to reduced use of feeding tubes and a reduction in length of stay (LOS) in the neonatal intensive care unit (NICU). Dr. Dongli Song, the principal investigator of the trial at Santa Clara Valley Medical Center in San Jose, California, received notification that the Pediatric Academic Societies (PAS) group has accepted two abstracts for poster presentation at the annual meeting.
“We are excited to have the opportunity to present our study at PAS. Achieving independent oral feeding represents an essential developmental milestone for premature infants. We need innovative therapies to improve their feeding readiness,” said Dr. Song. “I hope our presentation at this international conference will bring greater attention to this important issue.”
“This is an exciting development that will help the neonatal community better understand the developmental needs and capabilities of the premature infant,” said Michael Peck, CEO of Innara Health. “The reduced requirement for tube feeding, supported by the trial, could result in improved patient safety and reduced healthcare costs, as well as help these infants get home to their families sooner.”
The poster presentation of the trial will demonstrate objective data from 189 patients in a randomized control trial conducted at Santa Clara Valley Medical Center in San Jose, California; Children's Hospital at Montefiore-Weiler Division, Albert Einstein College of Medicine in Bronx, New York; Cook Children's Medical Center in Fort Worth, Texas; Children's Hospital at Montefiore-Wakefield Division, Albert Einstein College of Medicine in Bronx, New York; and North Central Baptist Hospital in San Antonio, Texas. The two poster sessions are scheduled to be presented at PAS in late April 2016.
About Innara Health
Innara Health’s mission is to advance the global understanding and improvement of neonatal, pediatric and adult feeding. The company offers the FDA-cleared NTrainer System, the first neonatal technology that assesses and develops non-nutritive suck (NNS) for newborns and infants born prematurely. Neonatal clinicians use the NTrainer System in children’s hospitals, medical centers and rehabilitation hospitals. For more information, visit innarahealth.com.
Contact Wendy Slatery Telephone 913-742-4456 E-mail [email protected]
